Blog
RSS FeedPosted by Michael Wonder on 23 Nov 2016
TGA approves extended use of Harvoni
23 November 2016 - The TGÅ has approved the use of Harvoni in additional genotypes. ...
Posted by Michael Wonder on 23 Nov 2016
Belsomra finally approved by TGA
23 November 2016 - The TGA has approved MSD's orexin receptor antagonist. ...
Posted by Michael Wonder on 23 Nov 2016
Halaven cleared by TGA for sarcoma
23 November 2016 - Eisai bags a second use for its halichondrin B analogue. ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves another Opdivo for another cancer type
23 November 2016 - The TGA has sanctioned the use of nivolumab for use by patients with renal cell carcinoma. ...
Posted by Michael Wonder on 23 Nov 2016
AusPAR user survey results
23 November 2016 - The survey was to help the TGA identify the audience for AusPARs, understand what AusPARs were being ...
Posted by Michael Wonder on 20 Nov 2016
TGA approves Grifols' Prolastin C
17 November 2016 - The TGA has approved Grifols' new alfa-1-proteinase inhibitor. ...
Posted by Michael Wonder on 17 Nov 2016
TGA approves Ninlaro
17 November 2016 - The TGA has approved Takeda's proteasome inhibitor for use by patients with multiple myeloma. ...
Posted by Michael Wonder on 14 Nov 2016
TGA key performance indicators: July 2015 to June 2016
14 November 2016 - The TGA has published a self-assessed rating of its overall performance for the year ending 30 ...
Posted by Michael Wonder on 02 Nov 2016
TGA publishes AusPAR for Esmya
2 November 2016 - The TGA has published an AusPAR for Vifor Pharma's Esmya. ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves new combination product for type 2 diabetes
31 October 2016 - The TGA has approved AstraZeneca's Qtern (saxagliptin hydrochloride with dapagliflozin propanediol monohydrate). ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves yet another use for Humira (adalimumab)
31 October 2016 - AbbVie clocks up another indication for its TNF-alfa inhibitor. ...
Posted by Michael Wonder on 20 Oct 2016
Members unite in response to R&D tax incentive review
20 October 2016 - More than 100 members have attended AusBiotech consultation meetings this week or made submissions, as the ...
Posted by Michael Wonder on 18 Oct 2016
TGA publishes AusPAR for Keytruda
18 October 2016 - The TGA has finally published an AusPAR for MSD's PD-1 inhibitor. ...
Posted by Michael Wonder on 15 Oct 2016
Medical devices: 3D pioneer Paul D’Urso calls for level field
15 October 2016 - Melbourne neurosurgeon Paul D’Urso has warned that Australian medical device manufacturers are locked out of the ...
Posted by Michael Wonder on 14 Oct 2016
TGA publishes AusPAR for Actemra
14 October 2016 - The TGA has published an AusPAR for the new formulation of Roche's Actemra (tocilizumab). ...